What to know about Trump’s plan to reduce drug prices

president Donald Trump Declared plans to reduce the prices of prescribed medicines, claiming that the United States will start paying the “lowest existing price in the world” for medicines.

On Monday, the “most obvious” executive order aimed to reduce the burden of prescription medications, a long source of concern for many Americans.

This is what to know:

“The United States will not support health care of foreign countries, which we do. We support others,” Trump said at a press conference on Monday.

He said that in some cases, the United States was paying “ten times more” against the same medications. Trump also said Pharmaceutical companies Make more than two -thirds of their profits in America, although the United States represents a small part of the world’s population.

Trump signs the executive order that aims to enhance the manufacture of American prescribed drugs

Trump claimed that in the wake of the executive order, “some prices of drugs and pharmaceutical preparations will be reduced immediately by 50 to 80 to 90 %.” This was an increase from one of the Sunday Post on the social truth, as he said that the prices of drugs and pharmaceutical preparations will be “immediately” by 30 % to 80 %.

“We will pay The lowest price there in the world. We will get someone to pay the lowest price. This is the price that we will get. ”

No details about how the administration plans to reduce the costs of Americans. However, he pointed out that large pharmaceutical companies “will either adhere to this principle voluntarily, or will use the authority of the federal government to ensure that we are paying the same price as other countries to accelerate these price restrictions and their reductions.”

RFK JR. The United States says low in health results, despite the disappearance of other countries

He also said that his administration will “completely cut the famous mediator”.

PBMS negotiates with manufacturers and pharmacies to determine prices, determining patients’ access to medicines and managing pharmacy networks. According to the Commonwealth Fund, PBMS has financial incentives that may contribute to high prices of medicines, high costs outside the pocket for patients, and Close independent pharmaciesEspecially in rural areas and low -income societies.

“The rest of the world will have to pay a little more, and America will pay much less … What we do is basically a tie,” he added.

During the press conference on Monday, Dr. Mohamed Oz, President Medical care centers Medicaid services, she said that the nation will remain “the treatment of cancer and a large number of other diseases that affect humanity” and that the country “will remain the pioneer in this field.”

However, “we will pay the appropriate amount, the correct amount of these tasks.”

Next month, Oz said that he will join a group of leaders, including the Minister of Health, Humanitarian Services and Humanitarian Services (HHS) Robert F. Kennedy Junior, in talking to pharmaceutical companies “specifically about what we want the price of the most preferred nation is based on the best data that we have.”

“We look forward to a deliberate interaction with the leaders of companies, who we spoke with and calm will agree that the system is not true as it is. They are national American.”

In 2022, US prices for all medicines, including brands and medicine services, were about 2.8 times a price in comparison countries, according to an assistant secretary and evaluation secretary.

Get Fox Business on the Go by clicking here

For brand drugs in particular, American prices were at least high 3.2 to prices in comparison countries, even after modifications to American estimated discounts.

The United States spends a higher and growing share of total drug spending on new drugs compared to other countries. While health care is often InsuranceMore cost burden is transferred to consumers with an increasing coverage of medical prescription insurance.